|

Medroxyprogesterone Acetate 500 MG Clinical Trials

2 actively recruiting trials

Also known as: Medroxyprogesterone Acetate

Pipeline

Phase 2: 1Phase 2/3: 1

Top Sponsors

  • Fudan University2

Indications

  • Cancer2
  • Fertility1
  • Endometrial Neoplasm Malignant Stage I1
  • Endometrial Cancer1

Other2 trials

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Phase 2
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.